...
首页> 外文期刊>Archives of cardiovascular diseases >Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events
【24h】

Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events

机译:肿瘤坏死因子α转换酶(TACE / ADAM17)和相关蛋白在冠状动脉疾病和心脏事件中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A?disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFα) and its receptors tumour necrosis factor alpha receptor?1 and tumour necrosis factor alpha receptor?2. There is evidence that TACE is involved in several inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.
机译:发明内容肿瘤坏死因子α转换酶(TACE / ADAM17)是Aα脱丁蛋白和金属蛋白酶(ADAM)胞外脱落蛋白酶家族的成员。它通过切割多种跨膜蛋白来调节许多炎症过程,包括肿瘤坏死因子α(TNFα)及其受体肿瘤坏死因子α受体?1和肿瘤坏死因子α受体?2。有证据表明TACE参与了几种炎症性疾病,例如患有缺血,心力衰竭,关节炎,动脉粥样硬化,糖尿病和癌症以及神经系统和免疫疾病。本综述总结了关于TACE行动机制的最新发现。它还专注于TACE在动脉粥样硬化和冠状动脉疾病(CAD)中的作用,突出了研究其表达和蛋白质活性的临床研究。通过TACE切割的众多底物使得该酶成为CAD中的生物标志物研究和发育的有吸引力的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号